~~<i id='B10F91D16D'><strike id='B10F91D16D'><tt id='B10F91D16D'><pre id='B10F91D16D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：Wikipedia 2025-10-01 10:59:19 - browse：249

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Change Healthcare can notify patients about the breach, HHS says

explore

focus

Wikipedia

knowledge

entertainment

knowledge

MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T

WSS

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Cord blood banking comes at a high cost to babies

Why failed clinical trials don’t always spell doom for a new drug

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

BMI, flaws aside, is found to be useful estimate of body fat in youth

knowledge

Wikipedia

explore

Activists slam private health insurers over coverage restrictions

Why failed clinical trials don’t always spell doom for a new drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Woman returns to dialysis after doctors remove transplanted pig kidney

After affirmative action ruling, medical educators look to 'holistic review'

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Anesthesiologist group: stop taking Ozempic before surgery

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Medicare proposal to cover medical devices draws a mixed reaction

Intellia reports positive results for its CRISPR

focus

Why failed clinical trials don’t always spell doom for a new drug

ASCO: AstraZeneca says CAR

Letters to First Opinion on caregivers, digital health, and more

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

How to use technology to prevent future drug shortages

Wikipedia

knowledge

entertainment

knowledge